healthy adult
Conditions
Interventions
11days usage of the test products daily starting 10 days after the start of menstruation. During the test period, test using an ovulation test kit every day.
Sponsors
Miura Clinic, Medical Corporation Kanonkai
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: (1)Subjects of women having period aged 20 to 40 (2) Subjects who received sufficient explanation about the purpose and content of the test, had the ability to consent, voluntarily volunteered to participate after understanding it well, and agreed to participate in the test in writing.
Exclusion criteria
Exclusion criteria: (1) Subjects with a history of diabetes, liver disease, renal disease, gastrointestinal disease, heart disease, respiratory disease, peripheral vascular disease, or other serious disease (2) Subjects who have undergone surgery on the digestive organs (3) Subjects with abnormal liver function and renal function test values (4) Subjects with diseases currently being treated (5) Subjects who are allergic to foods and drugs (6) Subjects with anemia symptoms (7) Women undergoing infertility treatment and those who have been diagnosed with polycystic ovary syndrome (8)Use of hormonal contraceptives, use of hormone replacement therapy, fertility drugs, artificial insemination, IVF, ICSI Those who are undergoing other medical treatments, such as adjuvant fertility therapy. (9) Subjects wishing to become pregnant while participating in this study, pregnant (including those who may be pregnant) or lactating female subjects (10) Subjects or a close family member who works for Cranebio Co., Ltd., Unicharm Co., Ltd., or their affiliates. (11) Subjects who play intense sports and subjects who are on a diet (12) Subjects with extremely irregular eating habits (13) Subjects who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and quasi-drugs during the test period (14) Subjects who are continuously receiving medical treatment (including OTC and prescription drugs) (15) Subjects who drink more than 60 g of average daily pure alcohol (16) Subjects who smoke an average of 21 or more cigarettes a day (17) Subjects who are participating in or will participate in other clinical trials at the start of this study (18) Other subjects judged by the investigator or the investigator to be inappropriate for the examination
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biomarker response by using test products Results of ovulation tests(2 types) | — |
Countries
Japan
Contacts
Public ContactMakoto Terashima
Oneness Support Co., Ltd. Clinical Trial Division
Outcome results
None listed